Teacher Retirement System of Texas Increases Position in Astrana Health, Inc. (NASDAQ:ASTH)

Teacher Retirement System of Texas raised its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 415.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 81,207 shares of the company’s stock after buying an additional 65,449 shares during the period. Teacher Retirement System of Texas owned about 0.14% of Astrana Health worth $2,560,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of ASTH. Handelsbanken Fonder AB boosted its holdings in Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock valued at $281,000 after acquiring an additional 400 shares during the period. Swiss National Bank grew its holdings in shares of Astrana Health by 1.1% in the fourth quarter. Swiss National Bank now owns 88,444 shares of the company’s stock valued at $2,789,000 after purchasing an additional 1,000 shares in the last quarter. KBC Group NV increased its stake in Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after buying an additional 1,316 shares during the period. Quarry LP acquired a new stake in Astrana Health during the 3rd quarter worth approximately $77,000. Finally, Moran Wealth Management LLC boosted its position in Astrana Health by 21.5% in the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock valued at $250,000 after buying an additional 1,404 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $30.79 on Thursday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20. The firm’s 50 day moving average is $33.99 and its two-hundred day moving average is $42.18. The firm has a market capitalization of $1.54 billion, a P/E ratio of 23.68, a P/E/G ratio of 1.37 and a beta of 1.30.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Research analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently weighed in on ASTH. Stifel Nicolaus cut their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Bank of America reduced their price target on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research report on Tuesday, March 4th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Robert W. Baird reduced their target price on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Finally, Truist Financial lowered their price target on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a report on Tuesday, March 18th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $56.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.